Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study
Yunlin Zhang(Hospital of the University of Pennsylvania), Marco Ruella(Parker Institute for Cancer Immunotherapy), Ositadimma Ugwuanyi(Hospital of the University of Pennsylvania), Yoon Lee(Advanced Biomass R&D Center (South Korea)), Ruchi P. Patel(University of Pennsylvania), Alberto Carturan(Hospital of the University of Pennsylvania), Dok Hyun Yoon(Ulsan College), Soohwan Kim(Dong-A University), Mathew G. Angelos(University of Pennsylvania), Seong Hyun Jeong(Ajou University Hospital), Ji Hyun Lee(JW Pharmaceutical (South Korea)), Jong-Seo Lee(Advanced Biomass R&D Center (South Korea)), Jae‐Cheol Jo(Ulsan College), Guido Ghilardi(Hospital of the University of Pennsylvania), Luca Paruzzo(Hospital of the University of Pennsylvania), Yoon Seok Choi(Ajou University Hospital), Puneeth Guruprasad(Parker Institute for Cancer Immunotherapy), LeiGuang Cui, Jong Hyun Cho(Rutgers, The State University of New Jersey), Junho Chung(Cancer Research Institute), Patrizia Porazzi(Hospital of the University of Pennsylvania), Sung Yong Oh(Korea University Medical Center), Raymone Pajarillo(Hospital of the University of Pennsylvania), Hyungwoo Cho(Ulsan College), Michael Wang(St. Joseph Health System), Sung‐Min Kim(Dong-A University), Sung Hyun Kim(Celltrion (South Korea)), Ki Hyun Kim(Chonnam National University Hwasun Hospital), Ji‐Ho Park(Korea Advanced Institute of Science and Technology), Yongjun Lee(Bucheon University), Jong‐Hoon Kim(Pohang University of Science and Technology), Hyun‐Jong Lee, Dongfang Liu(Rutgers, The State University of New Jersey), Young‐Ha Lee(Chungnam National University), In-Sik Hwang, Yong Gu Lee(Parker Institute for Cancer Immunotherapy), Ivan Cohen(Hospital of the University of Pennsylvania), Taebum Lee
Cited by 32
Related Papers
TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions
|Nucleic Acids Research|2017|2.1k
GABA-modulating bacteria of the human gut microbiota
|Nature Microbiology|2018|1.1k
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
|JAMA Oncology|2019|829
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
|Journal of Clinical Investigation|2016|554